Atropine eye drops have been used for many years to try and control the progression of myopia. The higher concentrations used were good at slowing down change in myopia but they had issues with side effects. We now have clear evidence from large research studies showing that low concentration Atropine eye drops also reduce the progression of myopia and have a very low incidence of side effects.
Initially there were studies such as the ATOM2 study in 2015 that appeared to show 0.01% concentration Atropine drops were effective for myopia control. Further analysis in 2020 went on to show that 0.01% concentration Atropine drops in fact did not slow myopia progression at all. Further, they found the use of 0.01% Atropine drops “unfortunate and concerning” as it “would inevitably delay implementation of an effective dose”. In line with the latest research, at Visique we use the slightly higher 0.025% and 0.05% concentration Atropine Myopia Control eye drops for this method of myopia control.
At this time we don’t have conclusive evidence about how much low dose Atropine eye drops slow myopia progression long term, or how effective it is over the age of 12, but based on the LAMP research the myopia control effect for age 12 years and under is up to 51% when using 0.025% and 0.05% concentration Myopia Control eye drops.
Remember glasses or contact lenses still need to be worn during the day if using Atropine drops.